Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

This publication has 33 references indexed in Scilit:

• Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
  International Journal of Obesity, 2004
• Prevention Conference VII
  Circulation, 2004
• The endocannabinoid system and its therapeutic exploitation
  Nature Reviews Drug Discovery, 2004
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  The Lancet, 2004
• The obesity epidemic, metabolic syndrome and future prevention strategies
  European Journal of Preventive Cardiology, 2004
• Endogenous cannabinoid system as a modulator of food intake
  International Journal of Obesity, 2003
• The cannabinoid receptors
  Prostaglandins & Other Lipid Mediators, 2002
• Molecular characterization of a peripheral receptor for cannabinoids
  Nature, 1993
• Structure of a cannabinoid receptor and functional expression of the cloned cDNA
  Nature, 1990
• The Hospital Anxiety and Depression Scale
  Acta Psychiatrica Scandinavica, 1983